Two or more dexamethasone intravitreal implants as monotherapy or in combination therapy for macular edema in retinal vein occlusion: subgroup analysis of a retrospective chart review study [PDF]
Antonio Capone Jr +10 more
core +1 more source
Clinical effectiveness of the 0.18 mg fluocinolone acetonide intravitreal implant for non-infectious uveitis-associated macular edema: a real-world study. [PDF]
Chen C +7 more
europepmc +1 more source
Treatment of Diabetic Macular Edema (DME): Shifting paradigms [PDF]
González Cortés, Jesús Hernán
core +1 more source
Early Switch to Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema Poorly Responding to Anti-VEGF Therapy: A Narrative Review. [PDF]
Sacconi R +8 more
europepmc +1 more source
Ricardo Machado Soares,* Catarina Cunha Ferreira,* Joana da Silva Fernandes, Carolina Madeira, Luís MA Silva, Eduardo Saraiva, Lígia Ribeiro, Sofia Fonseca Department of Ophthalmology - Centro Hospitalar Vila Nova de Gaia e Espinho, Porto ...
Soares RM +7 more
doaj
Paraneoplastic vitelliform retinopathy successfully treated with intravitreal dexamethasone implants. [PDF]
Natividade MS +5 more
europepmc +1 more source
Therapeutic Outcomes of Anti-VEGF Agents Versus Corticosteroids in Diabetic Macular Edema: A Comparative Review. [PDF]
Sanaka S, Yu M.
europepmc +1 more source
Pharmacological Treatment for Diabetic Macular Edema: A 2025 Update on Durability and Multi-Target Therapies. [PDF]
Tao Y, Zhang Y, Xu W, Liu G, Liu H.
europepmc +1 more source
Management of diabetic macular edema: from anti-VEGF to emerging therapies. [PDF]
Ji M, Wei W, Gong H, Zhang G.
europepmc +1 more source
Real-World Clinical Outcomes After Sustained Delivery of the 0.19 mg Fluocinolone Acetonide Implant for Treatment of Diabetic Macular Edema. [PDF]
Godel S, Oncel D, Donkor R, Coney JM.
europepmc +1 more source

